These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 28438506)

  • 1. Diacylglycerol Kinase ζ Limits Cytokine-dependent Expansion of CD8
    Andrada E; Liébana R; Merida I
    EBioMedicine; 2017 May; 19():39-48. PubMed ID: 28438506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diacylglycerol kinase ζ limits IL-2-dependent control of PD-1 expression in tumor-infiltrating T lymphocytes.
    Arranz-Nicolás J; Martin-Salgado M; Rodríguez-Rodríguez C; Liébana R; Moreno-Ortiz MC; Leitner J; Steinberger P; Ávila-Flores A; Merida I
    J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33246984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DGKζ exerts greater control than DGKα over CD8
    Gu J; Wang C; Cao C; Huang J; Holzhauer S; Desilva H; Wesley EM; Evans DB; Benci J; Wichroski M; Wee S; Riese MJ
    Oncoimmunology; 2021; 10(1):1941566. PubMed ID: 34350062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predominant contribution of DGKζ over DGKα in the control of PKC/PDK-1-regulated functions in T cells.
    Ávila-Flores A; Arranz-Nicolás J; Andrada E; Soutar D; Mérida I
    Immunol Cell Biol; 2017 Jul; 95(6):549-563. PubMed ID: 28163304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased diacylglycerol metabolism enhances ERK activation and augments CD8+ T cell functional responses.
    Riese MJ; Grewal J; Das J; Zou T; Patil V; Chakraborty AK; Koretzky GA
    J Biol Chem; 2011 Feb; 286(7):5254-65. PubMed ID: 21138839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced effector responses in activated CD8+ T cells deficient in diacylglycerol kinases.
    Riese MJ; Wang LC; Moon EK; Joshi RP; Ranganathan A; June CH; Koretzky GA; Albelda SM
    Cancer Res; 2013 Jun; 73(12):3566-77. PubMed ID: 23576561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T Cells Deficient in Diacylglycerol Kinase ζ Are Resistant to PD-1 Inhibition and Help Create Persistent Host Immunity to Leukemia.
    Jing W; Gershan JA; Holzhauer S; Weber J; Palen K; McOlash L; Pulakanti K; Wesley E; Rao S; Johnson BD; Riese MJ
    Cancer Res; 2017 Oct; 77(20):5676-5686. PubMed ID: 28916658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TCR signaling intensity controls CD8+ T cell responsiveness to TGF-β.
    Arumugam V; Bluemn T; Wesley E; Schmidt AM; Kambayashi T; Malarkannan S; Riese MJ
    J Leukoc Biol; 2015 Nov; 98(5):703-12. PubMed ID: 26153417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ζ isoform of diacylglycerol kinase plays a predominant role in regulatory T cell development and TCR-mediated ras signaling.
    Joshi RP; Schmidt AM; Das J; Pytel D; Riese MJ; Lester M; Diehl JA; Behrens EM; Kambayashi T; Koretzky GA
    Sci Signal; 2013 Nov; 6(303):ra102. PubMed ID: 24280043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diacylglycerol kinases in cancer.
    Mérida I; Torres-Ayuso P; Ávila-Flores A; Arranz-Nicolás J; Andrada E; Tello-Lafoz M; Liébana R; Arcos R
    Adv Biol Regul; 2017 Jan; 63():22-31. PubMed ID: 27697466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unexpected positive control of NFκB and miR-155 by DGKα and ζ ensures effector and memory CD8+ T cell differentiation.
    Yang J; Zhang P; Krishna S; Wang J; Lin X; Huang H; Xie D; Gorentla B; Huang R; Gao J; Li QJ; Zhong XP
    Oncotarget; 2016 Jun; 7(23):33744-64. PubMed ID: 27014906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diacylglycerol kinase α inhibition cooperates with PD-1-targeted therapies to restore the T cell activation program.
    Arranz-Nicolás J; Martin-Salgado M; Adán-Barrientos I; Liébana R; Del Carmen Moreno-Ortíz M; Leitner J; Steinberger P; Ávila-Flores A; Merida I
    Cancer Immunol Immunother; 2021 Nov; 70(11):3277-3289. PubMed ID: 33837851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diacylglycerol kinase α inactivation is an integral component of the costimulatory pathway that amplifies TCR signals.
    Arranz-Nicolás J; Ogando J; Soutar D; Arcos-Pérez R; Meraviglia-Crivelli D; Mañes S; Mérida I; Ávila-Flores A
    Cancer Immunol Immunother; 2018 Jun; 67(6):965-980. PubMed ID: 29572701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diacylglycerol kinase ζ limits the polarized recruitment of diacylglycerol-enriched organelles to the immune synapse in T cells.
    Andrada E; Almena M; de Guinoa JS; Merino-Cortes SV; Liébana R; Arcos R; Carrasco S; Carrasco YR; Merida I
    Sci Signal; 2016 Dec; 9(459):ra127. PubMed ID: 27999176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential regulation of primary and memory CD8 T cell immune responses by diacylglycerol kinases.
    Shin J; O'Brien TF; Grayson JM; Zhong XP
    J Immunol; 2012 Mar; 188(5):2111-7. PubMed ID: 22271650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Manipulation of diacylglycerol and ERK-mediated signaling differentially controls CD8
    Harabuchi S; Khan O; Bassiri H; Yoshida T; Okada Y; Takizawa M; Ikeda O; Katada A; Kambayashi T
    Front Immunol; 2022; 13():1032113. PubMed ID: 36846018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined inhibition/silencing of diacylglycerol kinase α and ζ simultaneously and synergistically enhances interleukin-2 production in T cells and induces cell death of melanoma cells.
    Takao S; Akiyama R; Sakane F
    J Cell Biochem; 2021 May; 122(5):494-506. PubMed ID: 33399248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Negative control of diacylglycerol kinase ζ-mediated inhibition of T cell receptor signaling by nuclear sequestration in mice.
    Xie D; Zhang S; Chen P; Deng W; Pan Y; Xie J; Wang J; Liao B; Sleasman JW; Zhong XP
    Eur J Immunol; 2020 Nov; 50(11):1729-1745. PubMed ID: 32525220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced T cell responses due to diacylglycerol kinase zeta deficiency.
    Zhong XP; Hainey EA; Olenchock BA; Jordan MS; Maltzman JS; Nichols KE; Shen H; Koretzky GA
    Nat Immunol; 2003 Sep; 4(9):882-90. PubMed ID: 12883552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination OX40 agonism/CTLA-4 blockade with HER2 vaccination reverses T-cell anergy and promotes survival in tumor-bearing mice.
    Linch SN; Kasiewicz MJ; McNamara MJ; Hilgart-Martiszus IF; Farhad M; Redmond WL
    Proc Natl Acad Sci U S A; 2016 Jan; 113(3):E319-27. PubMed ID: 26729864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.